Longeveron Shares Are Trading Higher After the Company Announced That the FDA Granted Fast Track Designation to Lomecel-B for the Treatment of Mild Alzheimer's Disease
在公司宣布FDA授予Lomecel-b治疗轻度阿尔茨海默病的快速通道资格后,Longeveron股票价格上涨。
Longeveron Shares Are Trading Higher After the Company Announced That the FDA Granted Fast Track Designation to Lomecel-B for the Treatment of Mild Alzheimer's Disease
在公司宣布FDA授予Lomecel-b治疗轻度阿尔茨海默病的快速通道资格后,Longeveron股票价格上涨。
使用浏览器的分享功能,分享给你的好友吧